Inovio pharmaceuticals stock.

Find the latest Inovio Pharmaceuticals, Inc. (INO) stock quote, history, news and other vital information to help you with your stock trading and investing. Home. ... Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13 ...4 Mar 2020 ... Shares of Inovio Pharmaceuticals Inc., the genetic vaccine company, hit a four-year high Wednesday, rising as much as 16% to $9.40 a share ...64.39%. Get the latest Inovio Pharmaceuticals Inc (INO) real-time quote, historical performance, charts, and other financial information to help you make more informed …The latest closing stock price for Inovio Pharmaceuticals as of November 17, 2023 is 0.43. The all-time high Inovio Pharmaceuticals stock closing price was 191.04 on March 03, 2000. The Inovio Pharmaceuticals 52-week high stock price is 2.17, which is 404.7% above the current share price. The Inovio Pharmaceuticals 52-week low stock price is 0. ...

Shares Outstanding: As of June 30, 2023, INOVIO had 268.1 million common shares outstanding and 290.0 million common shares outstanding on a fully diluted basis, after giving effect to the exercise, vesting and conversion, as applicable, of its outstanding options, restricted stock units, convertible preferred stock, and convertible debt.PLYMOUTH MEETING - INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that first quarter 2023 financial results will be released after the market close on May 10, 2023.. …

Galectin Therapeutics Inc. 1.99. -0.13. -6.13%. Get Inovio Pharmaceuticals Inc (INO:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.The Food and Drug Administration reversed a decision that barred Inovio Pharmaceuticals from testing its ... Inovio stock hit a high mark of 33.79 in June 2020 after the biotech company received a ...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its ... INO is the ticker symbol for Inovio Pharmaceuticals, Inc., a biotechnology company that develops and commercializes DNA medicines to treat and protect people from HPV-associated diseases, cancer, and infectious diseases. The web page shows its stock price, news, analysis, and performance outlook on NasdaqGS. Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. About the company. INO fundamental analysis.Please complete this form relating to your transactions for Inovio Pharmaceuticals, Inc. (Nasdaq: INO) common stock between February 14, 2020 and March 9, ...Oct. 10, 2023, 08:26 AM. (RTTNews) - Biotechnology company Inovio Pharmaceuticals, Inc. (INO) announced Tuesday that it has received feedback from the U.S. Food and Drug Administration (FDA) that ...Web

Nov 29, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Inovio Pharmaceuticals stock is Hold based on the current 1 hold rating for INO. The average twelve-month price prediction for Inovio Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00.

INO | Complete Inovio Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Inovio Pharmaceuticals (INO-5.75%) stock rose slightly on an otherwise gloomy day for the wider market. Investors were cheered by the appointment of a new chief medical officer at their company.Jun 27, 2023 · She was appointed as CEO on 05/10/2022. At the outset of her term on 05/11/2022 Inovio opened at $1.95. It has only managed to close above $2.49 on a scant few days, never >$3.00 as shown by the ... Nov 16, 2023 · Future criteria checks 2/6. Inovio Pharmaceuticals is forecast to grow earnings and revenue by 36.7% and 80.4% per annum respectively while EPS is expected to grow by 46.7% per annum. Inovio Pharmaceuticals, Inc. reports earnings ... In a free sample issue of our monthly newsletter we analyzed Warren Buffett’s stock picks covering the 1999-2017 period and identified the ...WebInovio Pharmaceuticals (INO) Company Description: Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA ...Inovio Pharmaceuticals (INO-5.34%) has given different groups of investors some wildly varying stock performances this year. If you bought its shares at the beginning of 2020, your investment is ...Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its ...

Let's consider two such stocks: Inovio Pharmaceuticals ( INO -2.10%) and Cronos Group ( CRON). INO data by YCharts. 1. Inovio Pharmaceuticals. Inovio Pharmaceuticals is a clinical-stage biotech ...INOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program 10-10 - 1 view Inovio Pharmaceuticals, Inc. Stock Option Grant Notice (2023 Omnibus Incentive Plan) 08-09 - 1 view Inovio Pharmaceuticals, Inc. RSU Award Grant Notice (2023 Omnibus Incentive …Inovio (INO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.WebMar 1, 2023 · Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021 Apr 13, 2023 · Shares of Inovio Pharmaceuticals (INO 0.96%) ... There's also the worry the stock could be delisted from the Nasdaq Stock Market if it continues to trade below $1, which would make it more ... Mar 1, 2023 · The year-over-year increase in G&A expenses was primarily due to a $14.0 million non-cash expense related to the settlement of INOVIO's securities class action litigation, including the issuance of INOVIO common stock as part of the settlement, $14.3 million in higher legal expenses, primarily related to litigation matters, $6.9 million in one ...

According to the issued ratings of 1 analysts in the last year, the consensus rating for Inovio Pharmaceuticals stock is Hold based on the current 1 hold rating for INO. The average twelve-month price prediction for Inovio Pharmaceuticals is $2.00 with a high price target of $2.00 and a low price target of $2.00.

Inovio Pharmaceuticals: Implied upside of 434%. But the crème de la crème of upside opportunity, at least on this list, is clinical-stage biotech stock Inovio Pharmaceuticals (INO 0.96%).Web3 Jan 2023 ... This could mean hype has come out of the stock because the bottom line is concerning investors. Generally speaking investors would consider ...1 Wall Street analysts have issued twelve-month target prices for Inovio Pharmaceuticals' stock. Their INO share price targets range from $2.00 to $2.00. On average, they predict the company's stock price to reach $2.00 in the next year. This suggests a possible upside of 423.3% from the stock's current price.Aug 26, 2022 · Inovio's stock price has fluctuated widely since the start of 2020, trading at a high of $31.63 per share and a low of $1.38. It opened Friday at $2.51 per share. INO-4201 found to be well-tolerated in the trial Humoral responses were boosted in 100% (36 of 36) of treated participants INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today …WebShares of coronavirus vaccine developer Inovio Pharmaceuticals ( INO 1.39%) are down 11% to $8.50 apiece as of 10:30 a.m. EDT. The company reported second-quarter earnings after markets closed on ...WebInovio Pharmaceuticals. Market Cap. $111M. Today's Change. (2.77%) $0.01. Current Price. Price as of November 24, 2023, 1:00 p.m. ET. You’re reading a free article with opinions that may differ ...Nov 28, 2023 · 52-week High/Low: $2.07 / $0.32. 50/200 Day Moving Average: $0.407 / $0.664. This figure corresponds to the Average Price over the previous 50/200 days. For Inovio Pharmaceuticals stocks, the 50-day moving average is the support level today. For Inovio Pharmaceuticals stocks, the 200-day moving average is the resistance level today. Apr 4, 2023 · Inovio's recent share drop below $1.00 is a new and unprecedented development. You have to travel deep into the wayback machine to 02/2009 to find intraday Inovio trading below $1.00. You have to ... A high-level overview of Inovio Pharmaceuticals, Inc. (INO) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

10 Okt 2023 ... Inovio Pharmaceuticals (INO) shares rise after FDA issued positive feedback on its plans to obtain marketing nod for lead asset against a ...

Inovio Pharmaceuticals Inc INO Morningstar Rating Unlock Stock XNAS Rating as of Nov 30, 2023 Summary Chart News Price vs Fair Value Sustainability …

Get Inovio Pharmaceuticals Inc (INO.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Inovio Pharmaceuticals (NASDAQ:INO) adds US$37m to market cap in the past 7 days, though investors from a year ago are still down 69%. (Simply Wall St.) Nov-18-22 11:42AM. Within A Month After Pulling Plug On COVID-19 Booster Study, Inovio Shelves Two More Infectious Disease Programs. Share Price as of November 9 4:00:00 PM EST Inovio Pharmaceuticals (INO) Stock Price Performance Inovio Pharmaceuticals (INO) Stock Key Data Summary Additional Data …Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today (Motley Fool) +7.28%. 12:37PM Inovio Pharma Stops Work On INO-4800 As COVID-19 Heterologous Booster (Benzinga) 08:50AM Inovio discontinues efforts to develop Covid-19 vaccine booster (American City Business Journals) Oct-27-22 ...Inovio Pharmaceuticals ( INO) reported Q3 2023 earnings per share (EPS) of -$0.13, meeting estimates of -$0.13 by 0.29%. In the same quarter last year, Inovio Pharmaceuticals 's earnings per share (EPS) was -$0.15. Inovio Pharmaceuticals is expected to release next earnings on 02/28/2024, with an earnings per share (EPS) …WebDec 1, 2023 · Stock analysis for Inovio Pharmaceuticals Inc (INO:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Inovio Pharmaceuticals is an American biotechnology company focused on the discovery, development, ... Inovio in August 2020, claiming it exaggerated evidence of its coronavirus vaccine's efficacy in order to boost its stock price. License of electroporation deviceSimply Wall St • 19 days ago. Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript. Insider Monkey • 23 days ago. Track Inovio Pharmaceuticals …Inovio Pharmaceuticals: Implied upside of 434%. But the crème de la crème of upside opportunity, at least on this list, is clinical-stage biotech stock Inovio Pharmaceuticals (INO 0.96%).WebIf you are thinking of buying or selling Inovio Pharmaceuticals stock, you should check out this FREE detailed report on its balance sheet.. A Different Perspective. While the broader market lost ...

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA ...Inovio Pharmaceuticals, Inc. stockholders' equity: Preferred stock—par value $0.001; Authorized shares: 10,000,000, issued and outstanding shares: 9 at December 31, 2022 and 2021Inovio Pharmaceuticals (INO-5.75%) stock rose slightly on an otherwise gloomy day for the wider market. Investors were cheered by the appointment of a new chief medical officer at their company.Stock control is important because it prevents retailers from running out of products, according to the Houston Chronicle. Stock control also helps retailers keep track of goods that may have been lost or stolen.Instagram:https://instagram. prop firms futuresgood credit cards to build creditstock symbol stzis tradovate a broker Three months after bringing on a new CEO, Inovio has reached a settlement with investors over accusations that it exaggerated progress on its Covid-19 vaccine candidate. The biotech, once claiming ...Web latam stockshow much is a silver dollar worth 1979 Inovio Pharmaceuticals received the green light from regulators in the U.S. to run a late-stage study for its potential coronavirus vaccine. The company is planning to target countries where there ...Inovio Pharmaceuticals (INO 2.77%) Q2 2023 Earnings Call Aug 09, 2023, 4:30 p.m. ET. Contents: Prepared Remarks; Questions and Answers; Call Participants; Prepared Remarks: Operator. Good day, and ... cheap futures trading Inovio Pharmaceuticals Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time INO stock price.Inovio (INO) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.WebTrack Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors